Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D3X1TS
|
|||
| Drug Name |
BAY 1902607
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Cough [ICD-11: MD12; ICD-10: R05] | Phase 1/2 | [1] | |
| Company |
Bayer
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | P2X purinoceptor 3 (P2RX3) | Target Info | Antagonist | [2] |
| KEGG Pathway | Calcium signaling pathway | |||
| Neuroactive ligand-receptor interaction | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03535168) Repeat Doses of BAY1902607 in Healthy Males and Proof of Concept in Chronic Cough Patients. U.S. National Institutes of Health. | |||
| REF 2 | Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov. 2019 May;18(5):339-357. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.